James M. Markert

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

Robert L. Martuza, Amy Malick, James M. Markert et al. · Science · 1991 · 1K citations

Medicine, Cancer Biology, Oncology +14

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

James M. Markert, Michael D. Medlock, Samuel D. Rabkin et al. · Gene Therapy · 2000 · 978 citations

Medicine, Biomedical Sciences, Oncology +9

A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

E. Antonio Chiocca, Khalid M. Abbed, Stephen B. Tatter et al. · Molecular Therapy · 2004 · 440 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM

James M. Markert, Peter Liechty, Wenquan Wang et al. · Molecular Therapy · 2008 · 404 citations · Full text

Medicine, Oncology, Surgery +14

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

Jacqueline N. Parker, G. Yancey Gillespie, Cammy E. Love et al. · Proceedings of the National Academy of Sciences · 2000 · 334 citations

Life Sciences, Immunology, Oncology +13